Latest Insights on ARR
4 Reasons We’ll Finally Legalize Cannabis in 2022 December 2, 2021 U.S. Economy, Winning Investor Daily
Here are four key reasons why the U.S. will finally legalize cannabis in 2022…
On DoorDashers, On Box’ers, On Chipmakers … C’mon, Becto! December 1, 2021 Great Stuff
A Little Dash’ll Do Ya? It’s been, what … less than a week since COVID-19 Omicron debuted, and I’m already tired of it. And I’m sure you’re tired of hearing about Omicron as well, Great Ones. Wall Street is also tired of it, apparently, as stocks attempted to push sharply higher today. But, as resilient […]
December’s Market Outlook: Buy the Omicron Dip! December 1, 2021 Monthly Market Outlook, Trading Strategies, True Options Masters
In the last Monthly Market Outlook of the year, your True Options Masters share actionable trade ideas to buy the omicron dip!
Omicron’s Market Madness, Meta’s Gif Horse & Raptor’s Wreckage November 30, 2021 Great Stuff
Don’t Panic & Carry A Towel The market gets to the bottom then goes back to the top of the slide, where it stops and it turns and it goes for a ride … ‘till it gets to the bottom and it does it again! Yeah, yeah, yeah! Do you, don’t you want me to […]
A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 Big Picture. Big Profits., Global Economy, News
This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.MEET OUR EXPERTS
Director of VIP Services
Research Analyst
Chief Investment Strategist of Money & Markets
Editor of Alpha Investor
Editor of Strategic Fortunes and three elite services
